

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.21277453 |
| 2 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 4.10008445 |
| 3 | mitotic cell cycle arrest (GO:0071850) | 4.05221964 |
| 4 | sleep (GO:0030431) | 3.88652734 |
| 5 | rRNA modification (GO:0000154) | 3.85604778 |
| 6 | rRNA methylation (GO:0031167) | 3.84468837 |
| 7 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.73690428 |
| 8 | DNA deamination (GO:0045006) | 3.63151727 |
| 9 | UV protection (GO:0009650) | 3.48718796 |
| 10 | response to gravity (GO:0009629) | 3.48690111 |
| 11 | positive regulation of defense response to virus by host (GO:0002230) | 3.48284378 |
| 12 | regulation of defense response to virus by host (GO:0050691) | 3.45739627 |
| 13 | response to muramyl dipeptide (GO:0032495) | 3.44702083 |
| 14 | positive regulation of prostaglandin secretion (GO:0032308) | 3.44420307 |
| 15 | DNA strand renaturation (GO:0000733) | 3.41255663 |
| 16 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.40304360 |
| 17 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.39857456 |
| 18 | cellular response to ATP (GO:0071318) | 3.37371688 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.35067771 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.35067771 |
| 21 | cellular response to exogenous dsRNA (GO:0071360) | 3.30733369 |
| 22 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.29240954 |
| 23 | GDP-mannose metabolic process (GO:0019673) | 3.25090994 |
| 24 | positive regulation of heat generation (GO:0031652) | 3.21369047 |
| 25 | mast cell activation involved in immune response (GO:0002279) | 3.16736288 |
| 26 | mast cell degranulation (GO:0043303) | 3.16736288 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 3.09470420 |
| 28 | RNA destabilization (GO:0050779) | 3.08726794 |
| 29 | rRNA catabolic process (GO:0016075) | 3.08706875 |
| 30 | base-excision repair, AP site formation (GO:0006285) | 3.07150695 |
| 31 | mast cell activation (GO:0045576) | 3.06743646 |
| 32 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.04799731 |
| 33 | folic acid metabolic process (GO:0046655) | 3.01786005 |
| 34 | meiotic chromosome segregation (GO:0045132) | 2.97895327 |
| 35 | tRNA modification (GO:0006400) | 2.96180217 |
| 36 | regulation of prostaglandin secretion (GO:0032306) | 2.95234540 |
| 37 | regulation of germinal center formation (GO:0002634) | 2.93278393 |
| 38 | interferon-gamma production (GO:0032609) | 2.92434644 |
| 39 | pseudouridine synthesis (GO:0001522) | 2.92072165 |
| 40 | positive thymic T cell selection (GO:0045059) | 2.90998445 |
| 41 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88010933 |
| 42 | tolerance induction (GO:0002507) | 2.85800805 |
| 43 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.83659059 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.83015686 |
| 45 | piRNA metabolic process (GO:0034587) | 2.80553196 |
| 46 | negative regulation of cell aging (GO:0090344) | 2.74064168 |
| 47 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.73471731 |
| 48 | cellular response to dsRNA (GO:0071359) | 2.69766602 |
| 49 | DNA replication checkpoint (GO:0000076) | 2.69725206 |
| 50 | ribosome assembly (GO:0042255) | 2.68763201 |
| 51 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67991202 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66658074 |
| 53 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.65849993 |
| 54 | termination of RNA polymerase III transcription (GO:0006386) | 2.65849993 |
| 55 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.64114344 |
| 56 | methionine biosynthetic process (GO:0009086) | 2.63171235 |
| 57 | adenosine metabolic process (GO:0046085) | 2.63034942 |
| 58 | iron-sulfur cluster assembly (GO:0016226) | 2.62852087 |
| 59 | metallo-sulfur cluster assembly (GO:0031163) | 2.62852087 |
| 60 | leukocyte degranulation (GO:0043299) | 2.62541087 |
| 61 | negative thymic T cell selection (GO:0045060) | 2.62532589 |
| 62 | negative regulation of innate immune response (GO:0045824) | 2.60346273 |
| 63 | regulation of skeletal muscle contraction (GO:0014819) | 2.59016926 |
| 64 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.56807008 |
| 65 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.56013341 |
| 66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.55771399 |
| 67 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.53761419 |
| 68 | mitochondrial RNA metabolic process (GO:0000959) | 2.53671884 |
| 69 | RNA methylation (GO:0001510) | 2.51967464 |
| 70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.50805062 |
| 71 | nucleotide transmembrane transport (GO:1901679) | 2.47838183 |
| 72 | positive regulation of T cell cytokine production (GO:0002726) | 2.47342262 |
| 73 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.46372053 |
| 74 | negative T cell selection (GO:0043383) | 2.44879298 |
| 75 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.41648510 |
| 76 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.40911710 |
| 77 | positive regulation of T cell mediated immunity (GO:0002711) | 2.40367743 |
| 78 | regulation of memory T cell differentiation (GO:0043380) | 2.40128363 |
| 79 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.39554142 |
| 80 | response to interleukin-15 (GO:0070672) | 2.38933808 |
| 81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.38789143 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37833927 |
| 83 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.37294728 |
| 84 | L-methionine biosynthetic process (GO:0071265) | 2.36212550 |
| 85 | amino acid salvage (GO:0043102) | 2.36212550 |
| 86 | L-methionine salvage (GO:0071267) | 2.36212550 |
| 87 | tRNA methylation (GO:0030488) | 2.35907321 |
| 88 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.35852308 |
| 89 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.35852308 |
| 90 | isotype switching (GO:0045190) | 2.35852308 |
| 91 | regulation of immunoglobulin secretion (GO:0051023) | 2.34778283 |
| 92 | RNA modification (GO:0009451) | 2.34476751 |
| 93 | positive regulation of osteoclast differentiation (GO:0045672) | 2.34130615 |
| 94 | B cell homeostasis (GO:0001782) | 2.33076973 |
| 95 | termination of RNA polymerase I transcription (GO:0006363) | 2.32333525 |
| 96 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.31679948 |
| 97 | nuclear envelope reassembly (GO:0031468) | 2.31175290 |
| 98 | mitotic nuclear envelope reassembly (GO:0007084) | 2.31175290 |
| 99 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.30452349 |
| 100 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.28187004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.95474245 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.66199263 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.49143751 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.47637281 |
| 5 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.47599628 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40331058 |
| 7 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.39972621 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.30598566 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.22865324 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.22083077 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.19396296 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.18116663 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.17551371 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.13425555 |
| 15 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.11101187 |
| 16 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.03865649 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.02300731 |
| 18 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.97693218 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.97513385 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94218798 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93197611 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91960367 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.88156345 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 1.85302608 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.85210027 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80500682 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77218560 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.76800196 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72509586 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72100667 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69998476 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68020220 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67647513 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65437154 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.64207333 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63329426 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60888354 |
| 38 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.59819757 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58420433 |
| 40 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.56952848 |
| 41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56035843 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52297424 |
| 43 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.51408526 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.50194934 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49051424 |
| 46 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.47457518 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46678833 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.45612088 |
| 49 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.44403559 |
| 50 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43971447 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43968119 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43322484 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42530915 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42390757 |
| 55 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42365733 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42168420 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40545166 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40400175 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40250190 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38744422 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38240656 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37955723 |
| 63 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37618781 |
| 64 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.37179090 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.36402766 |
| 66 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34429053 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33711565 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.28312146 |
| 69 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27431597 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27312536 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24979584 |
| 72 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24633784 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23666357 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22563883 |
| 75 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.21169288 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20534722 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.19726714 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 1.19652495 |
| 79 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18955204 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18870197 |
| 81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.18840915 |
| 82 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18195313 |
| 83 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.17513090 |
| 84 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.17366995 |
| 85 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17141929 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16473706 |
| 87 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.13791230 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13564367 |
| 89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13291881 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12810638 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12052796 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10912625 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09161147 |
| 94 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.09011869 |
| 95 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08196658 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07930721 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07053852 |
| 98 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06977544 |
| 99 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05820522 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.05407391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.34379592 |
| 2 | MP0001986_abnormal_taste_sensitivity | 2.93442500 |
| 3 | MP0000685_abnormal_immune_system | 2.90378597 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.81020121 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.75746743 |
| 6 | MP0005174_abnormal_tail_pigmentation | 2.65605467 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.62707132 |
| 8 | MP0005671_abnormal_response_to | 2.59942611 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.33915574 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.32214037 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.30828756 |
| 12 | MP0002009_preneoplasia | 2.25571072 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17783065 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.15354063 |
| 15 | MP0002723_abnormal_immune_serum | 2.15264379 |
| 16 | MP0005171_absent_coat_pigmentation | 2.11032759 |
| 17 | MP0003724_increased_susceptibility_to | 2.10382739 |
| 18 | MP0001800_abnormal_humoral_immune | 2.01713375 |
| 19 | MP0002166_altered_tumor_susceptibility | 1.97735512 |
| 20 | MP0004947_skin_inflammation | 1.96625444 |
| 21 | MP0003786_premature_aging | 1.95420517 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.94820956 |
| 23 | MP0001819_abnormal_immune_cell | 1.83340945 |
| 24 | MP0002006_tumorigenesis | 1.81986472 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.81346127 |
| 26 | MP0002398_abnormal_bone_marrow | 1.81278202 |
| 27 | MP0008058_abnormal_DNA_repair | 1.80787557 |
| 28 | MP0003828_pulmonary_edema | 1.78528428 |
| 29 | MP0003693_abnormal_embryo_hatching | 1.77564542 |
| 30 | MP0002405_respiratory_system_inflammati | 1.70725252 |
| 31 | MP0005083_abnormal_biliary_tract | 1.69922221 |
| 32 | MP0001661_extended_life_span | 1.66620354 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.64931958 |
| 34 | MP0002722_abnormal_immune_system | 1.60678559 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.59726282 |
| 36 | MP0002019_abnormal_tumor_incidence | 1.57942535 |
| 37 | MP0009785_altered_susceptibility_to | 1.57006500 |
| 38 | MP0000716_abnormal_immune_system | 1.55000063 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.54456120 |
| 40 | MP0001873_stomach_inflammation | 1.53979544 |
| 41 | MP0002419_abnormal_innate_immunity | 1.53033654 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.49815909 |
| 43 | MP0002429_abnormal_blood_cell | 1.49805966 |
| 44 | MP0003077_abnormal_cell_cycle | 1.49392670 |
| 45 | MP0001853_heart_inflammation | 1.45411815 |
| 46 | MP0005025_abnormal_response_to | 1.44482644 |
| 47 | MP0002933_joint_inflammation | 1.43944996 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.41987870 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.41753430 |
| 50 | MP0009764_decreased_sensitivity_to | 1.35023603 |
| 51 | MP0001790_abnormal_immune_system | 1.34649101 |
| 52 | MP0005387_immune_system_phenotype | 1.34649101 |
| 53 | MP0001919_abnormal_reproductive_system | 1.32313780 |
| 54 | MP0009840_abnormal_foam_cell | 1.32287065 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.30132050 |
| 56 | MP0000858_altered_metastatic_potential | 1.29503283 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.26395750 |
| 58 | MP0003950_abnormal_plasma_membrane | 1.24175831 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.24160934 |
| 60 | MP0009278_abnormal_bone_marrow | 1.21220105 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.21028576 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.16129856 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.14629063 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.13288557 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.01104172 |
| 66 | MP0008469_abnormal_protein_level | 1.00621814 |
| 67 | MP0004147_increased_porphyrin_level | 0.98901302 |
| 68 | MP0001765_abnormal_ion_homeostasis | 0.98634998 |
| 69 | MP0000013_abnormal_adipose_tissue | 0.97646634 |
| 70 | MP0000358_abnormal_cell_content/ | 0.93569352 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 0.93040782 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.91968472 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 0.91643889 |
| 74 | MP0002160_abnormal_reproductive_system | 0.91628217 |
| 75 | MP0005410_abnormal_fertilization | 0.89221307 |
| 76 | MP0005389_reproductive_system_phenotype | 0.87433370 |
| 77 | MP0003718_maternal_effect | 0.87203044 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.83810839 |
| 79 | MP0005332_abnormal_amino_acid | 0.82569616 |
| 80 | MP0009931_abnormal_skin_appearance | 0.82191783 |
| 81 | MP0005423_abnormal_somatic_nervous | 0.79913998 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 0.78628981 |
| 83 | MP0000490_abnormal_crypts_of | 0.77920367 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.76619148 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.75357374 |
| 86 | MP0001968_abnormal_touch/_nociception | 0.73196926 |
| 87 | MP0001216_abnormal_epidermal_layer | 0.72777846 |
| 88 | MP0001243_abnormal_dermal_layer | 0.71125043 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.71080774 |
| 90 | MP0005501_abnormal_skin_physiology | 0.69859155 |
| 91 | MP0008057_abnormal_DNA_replication | 0.69597752 |
| 92 | MP0005330_cardiomyopathy | 0.67350933 |
| 93 | MP0000313_abnormal_cell_death | 0.67347702 |
| 94 | MP0002736_abnormal_nociception_after | 0.66326992 |
| 95 | MP0004043_abnormal_pH_regulation | 0.65948154 |
| 96 | MP0000747_muscle_weakness | 0.64293017 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.63299690 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.60672021 |
| 99 | MP0003448_altered_tumor_morphology | 0.60472660 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.57836399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Testicular atrophy (HP:0000029) | 4.52617636 |
| 2 | Attenuation of retinal blood vessels (HP:0007843) | 4.09020889 |
| 3 | IgG deficiency (HP:0004315) | 3.88832279 |
| 4 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.62145073 |
| 5 | Facial diplegia (HP:0001349) | 3.59649558 |
| 6 | Poikiloderma (HP:0001029) | 3.58761255 |
| 7 | Squamous cell carcinoma (HP:0002860) | 3.52740101 |
| 8 | Dyschromatopsia (HP:0007641) | 3.47303258 |
| 9 | Rectovaginal fistula (HP:0000143) | 3.40552144 |
| 10 | Rectal fistula (HP:0100590) | 3.40552144 |
| 11 | Vaginal fistula (HP:0004320) | 3.12887687 |
| 12 | Intestinal fistula (HP:0100819) | 3.12067425 |
| 13 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.97268138 |
| 14 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.91966502 |
| 15 | Absent thumb (HP:0009777) | 2.88973767 |
| 16 | Pustule (HP:0200039) | 2.81491939 |
| 17 | Increased hepatocellular lipid droplets (HP:0006565) | 2.73183218 |
| 18 | Progressive muscle weakness (HP:0003323) | 2.68951179 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67592274 |
| 20 | Abnormality of the pons (HP:0007361) | 2.66964808 |
| 21 | Mesangial abnormality (HP:0001966) | 2.64450909 |
| 22 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.63816712 |
| 23 | Joint stiffness (HP:0001387) | 2.61638323 |
| 24 | Hypoplasia of the pons (HP:0012110) | 2.61475004 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 2.61436863 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58389944 |
| 27 | Congenital stationary night blindness (HP:0007642) | 2.57567285 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 2.52794552 |
| 29 | Abnormal protein glycosylation (HP:0012346) | 2.52614384 |
| 30 | Abnormal glycosylation (HP:0012345) | 2.52614384 |
| 31 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52614384 |
| 32 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52614384 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 2.50228043 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.46152344 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46092138 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46092138 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46092138 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.44277554 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43874585 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43874585 |
| 41 | Type 2 muscle fiber atrophy (HP:0003554) | 2.41908941 |
| 42 | Premature graying of hair (HP:0002216) | 2.40017870 |
| 43 | Muscle fiber atrophy (HP:0100295) | 2.38162598 |
| 44 | Increased muscle lipid content (HP:0009058) | 2.35557345 |
| 45 | Rib fusion (HP:0000902) | 2.32602825 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.31878109 |
| 47 | Abnormal albumin level (HP:0012116) | 2.29117058 |
| 48 | Hypoalbuminemia (HP:0003073) | 2.29117058 |
| 49 | Abnormality of T cells (HP:0002843) | 2.28700582 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.28676566 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28676566 |
| 52 | Amniotic constriction ring (HP:0009775) | 2.27667658 |
| 53 | Abnormality of placental membranes (HP:0011409) | 2.27667658 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.22489102 |
| 55 | Abnormality of DNA repair (HP:0003254) | 2.19699688 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.19549140 |
| 57 | Entropion (HP:0000621) | 2.19175421 |
| 58 | Panhypogammaglobulinemia (HP:0003139) | 2.17557141 |
| 59 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.14875605 |
| 60 | Aplasia of the musculature (HP:0100854) | 2.13892244 |
| 61 | Ragged-red muscle fibers (HP:0003200) | 2.13725017 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.13538545 |
| 63 | Hemorrhage of the eye (HP:0011885) | 2.13157695 |
| 64 | Basal cell carcinoma (HP:0002671) | 2.13072260 |
| 65 | Patellar aplasia (HP:0006443) | 2.10640460 |
| 66 | Fatigue (HP:0012378) | 2.09978037 |
| 67 | Prostate neoplasm (HP:0100787) | 2.09733354 |
| 68 | T lymphocytopenia (HP:0005403) | 2.07788191 |
| 69 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.07284412 |
| 70 | Increased serum lactate (HP:0002151) | 2.06320349 |
| 71 | Cheilitis (HP:0100825) | 2.04548121 |
| 72 | Combined immunodeficiency (HP:0005387) | 2.04296888 |
| 73 | Abnormality of T cell number (HP:0011839) | 2.01730578 |
| 74 | Decreased central vision (HP:0007663) | 1.96842002 |
| 75 | Progressive microcephaly (HP:0000253) | 1.96752610 |
| 76 | Persistence of primary teeth (HP:0006335) | 1.96730682 |
| 77 | Choroideremia (HP:0001139) | 1.94108543 |
| 78 | IgA deficiency (HP:0002720) | 1.93292294 |
| 79 | Duplicated collecting system (HP:0000081) | 1.92545497 |
| 80 | Pancytopenia (HP:0001876) | 1.90982332 |
| 81 | Cerebellar dysplasia (HP:0007033) | 1.89881205 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 1.89635607 |
| 83 | Anorexia (HP:0002039) | 1.88768030 |
| 84 | Recurrent fungal infections (HP:0002841) | 1.87010186 |
| 85 | Myositis (HP:0100614) | 1.86823338 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 1.85443731 |
| 87 | Exertional dyspnea (HP:0002875) | 1.84875819 |
| 88 | Conical tooth (HP:0000698) | 1.84556822 |
| 89 | Opisthotonus (HP:0002179) | 1.83009247 |
| 90 | Increased IgM level (HP:0003496) | 1.82386901 |
| 91 | Popliteal pterygium (HP:0009756) | 1.82337317 |
| 92 | Joint hemorrhage (HP:0005261) | 1.82163567 |
| 93 | Hypergonadotropic hypogonadism (HP:0000815) | 1.81724826 |
| 94 | Stomatitis (HP:0010280) | 1.79023118 |
| 95 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.77956720 |
| 96 | Stomach cancer (HP:0012126) | 1.77116429 |
| 97 | Granulocytopenia (HP:0001913) | 1.76333759 |
| 98 | Clumsiness (HP:0002312) | 1.76178675 |
| 99 | Abnormal spermatogenesis (HP:0008669) | 1.75913460 |
| 100 | Epiphyseal stippling (HP:0010655) | 1.74931220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.30512469 |
| 2 | TESK2 | 4.26351961 |
| 3 | TAOK3 | 3.53191231 |
| 4 | TXK | 3.37479669 |
| 5 | ZAK | 3.18535765 |
| 6 | VRK2 | 3.01810099 |
| 7 | MAP3K14 | 2.87499173 |
| 8 | MUSK | 2.84121452 |
| 9 | GRK6 | 2.66671289 |
| 10 | MAP2K2 | 2.66040042 |
| 11 | IRAK3 | 2.51859571 |
| 12 | NEK1 | 2.41297874 |
| 13 | TBK1 | 2.22097541 |
| 14 | MAPK15 | 2.18990887 |
| 15 | STK16 | 1.91997177 |
| 16 | IKBKB | 1.88577477 |
| 17 | MAPKAPK3 | 1.74580704 |
| 18 | MAP4K1 | 1.64114142 |
| 19 | MAP4K2 | 1.59248432 |
| 20 | BCKDK | 1.57879455 |
| 21 | WNK4 | 1.52554727 |
| 22 | NUAK1 | 1.51214694 |
| 23 | IKBKE | 1.48260619 |
| 24 | BUB1 | 1.45648448 |
| 25 | NME2 | 1.43532228 |
| 26 | KDR | 1.39266042 |
| 27 | CDK8 | 1.30821518 |
| 28 | CCNB1 | 1.23312080 |
| 29 | CDK4 | 1.20837569 |
| 30 | KIT | 1.18775796 |
| 31 | SRPK1 | 1.16762288 |
| 32 | VRK1 | 1.10993129 |
| 33 | ZAP70 | 1.08999825 |
| 34 | STK10 | 1.08757183 |
| 35 | CSF1R | 1.07289032 |
| 36 | PDK2 | 1.03843641 |
| 37 | MAP2K3 | 0.91845603 |
| 38 | EIF2AK2 | 0.91702358 |
| 39 | MAPK11 | 0.91518974 |
| 40 | SIK2 | 0.91216098 |
| 41 | FES | 0.88903814 |
| 42 | DAPK1 | 0.85422345 |
| 43 | NEK2 | 0.80871842 |
| 44 | JAK3 | 0.80176998 |
| 45 | EPHA2 | 0.78390508 |
| 46 | AURKA | 0.77748373 |
| 47 | MST4 | 0.76484969 |
| 48 | SCYL2 | 0.74703732 |
| 49 | ADRBK2 | 0.74560121 |
| 50 | CHEK2 | 0.72726579 |
| 51 | PIM2 | 0.72227831 |
| 52 | EEF2K | 0.71959643 |
| 53 | SYK | 0.71825450 |
| 54 | MATK | 0.71486196 |
| 55 | RPS6KA5 | 0.70096965 |
| 56 | ITK | 0.69811318 |
| 57 | CHUK | 0.68727876 |
| 58 | ATR | 0.66501529 |
| 59 | TEC | 0.64643798 |
| 60 | RPS6KA2 | 0.62592148 |
| 61 | BLK | 0.61956949 |
| 62 | SMG1 | 0.60303149 |
| 63 | FLT3 | 0.59567711 |
| 64 | MAP2K6 | 0.57959292 |
| 65 | EIF2AK3 | 0.56577588 |
| 66 | LCK | 0.56443526 |
| 67 | PIM1 | 0.55927705 |
| 68 | BTK | 0.53760057 |
| 69 | JAK1 | 0.52641410 |
| 70 | LYN | 0.51626688 |
| 71 | LIMK1 | 0.48675886 |
| 72 | TRPM7 | 0.45423904 |
| 73 | ERN1 | 0.45190636 |
| 74 | MAPKAPK2 | 0.43470353 |
| 75 | RPS6KB2 | 0.43401117 |
| 76 | OXSR1 | 0.42035206 |
| 77 | MAP2K1 | 0.41437427 |
| 78 | AURKB | 0.41335070 |
| 79 | MAP3K13 | 0.40788703 |
| 80 | TRIB3 | 0.39138137 |
| 81 | BMPR2 | 0.38551590 |
| 82 | MAPKAPK5 | 0.37409526 |
| 83 | PRKCI | 0.36712920 |
| 84 | GRK1 | 0.35239861 |
| 85 | ADRBK1 | 0.32625351 |
| 86 | BRD4 | 0.32525757 |
| 87 | CDK7 | 0.32210651 |
| 88 | HCK | 0.32042448 |
| 89 | PRKD2 | 0.31620006 |
| 90 | CDK6 | 0.30667224 |
| 91 | MST1R | 0.30358178 |
| 92 | ABL1 | 0.29769436 |
| 93 | PBK | 0.29743262 |
| 94 | PLK1 | 0.29648101 |
| 95 | RPS6KA1 | 0.29551361 |
| 96 | PRKCQ | 0.28926573 |
| 97 | IRAK4 | 0.26440962 |
| 98 | PHKG2 | 0.25945361 |
| 99 | PHKG1 | 0.25945361 |
| 100 | PDPK1 | 0.25508467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.61518093 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.81060846 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.71415708 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.67744795 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.64058005 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.63843910 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.51264333 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.47648583 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.32200821 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26746849 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.25213279 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.16047658 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.15094455 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.09916705 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02926452 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.98863281 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.97968326 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.90393468 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.84644044 |
| 20 | Proteasome_Homo sapiens_hsa03050 | 1.84249065 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.81448021 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.77361237 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74388426 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74269186 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73686501 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60448007 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.58919748 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53837417 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53625317 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45980118 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43886207 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42774711 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37550517 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.36611703 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.36349066 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.30243250 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.29130191 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.28582468 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27633271 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24310077 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.21992648 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17658678 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13586902 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10855677 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03695507 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03389668 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03272488 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96331314 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.93401768 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 0.87448928 |
| 51 | Measles_Homo sapiens_hsa05162 | 0.87300357 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86028261 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.84732004 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.84235909 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82464616 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80456023 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76334118 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75315625 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.72760645 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72031523 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71606141 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69893551 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68961795 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68873268 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67628529 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67363215 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67268689 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.66577108 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65489944 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65452668 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.65201339 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.62013339 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.60232749 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58980318 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57850673 |
| 76 | Tuberculosis_Homo sapiens_hsa05152 | 0.53548278 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49731915 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.43023772 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42304407 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39419806 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38884928 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38862193 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.35594530 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.35395154 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34678524 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34320359 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32456505 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31897559 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29362413 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29284765 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29009209 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25049566 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.22851922 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.22245565 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.20515275 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.20111325 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.19670174 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.17223345 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17086715 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15868896 |

